HCPCS code Q5101 — Injection, zarxio. Status: Active. Effective Jan 1, 2024. Source: CMS HCPCS Level II.

Q5101

Active

Injection, zarxio

Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Jan 1, 2024
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 1822
Drug class: Hematopoietic Growth Factors (G-CSF/GM-CSF)

MUE — Medically Unlikely Edits

Maximum units of Q5101 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 0
Outpatient Hospital 1500
Practitioner Services 1500

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
61314-0318-01 Zarxio
61314-0318-10 Zarxio
61314-0326-01 Zarxio
61314-0326-10 Zarxio

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2024-Q1
    Injection, zarxio